Cabazitaxel versus docetaxel as first-line therapy for patients with metastatic castration-resistant prostate cancer: A randomized phase III trial - FIRSTANA

1. Oudard, S.
2. Fizazi, K.
3. Sengeløv, L.
4. Daugaard, G.
5. Saad, F.
6. Hansen, S.
7. Hjälm-Eriksson, M.
8. Jassem, J.
9. Thiery-Vuillemin, A.
10. Caffo, O.
11. Castellano, D.
12. Mainwaring, P.N.
13. Bernard, J.
14. Shen, L.
15. Chadjaa, M.
16. Sartor, O.